Table 2. Cox regression analysis of determinants of DFS in cohort A cancer patients.
| Univariate analysis |
Multivariate analysisa
|
||
|---|---|---|---|
| Parameters | P-valueb | HR (CI)c | P-value |
| Disease stage (I+II vs III+IV) | <0.001 | 4.5 (1.8–10.8) | 0.001 |
| Lymphatic invasion (− vs +) | <0.001 | — | — |
| Vascular invasion (− vs +) | 0.012 | — | — |
| Margin (expansive vs infiltrative) | 0.015 | — | — |
| GPS expression (high vs low) | 0.022 | — | — |
Abbreviation: DFS=disease-free survival
a
Final results of Cox regression analysis using a forward stepwise method (enter limit=0.05, remove limit=0.10).
b
Log-rank test P-value.
c
Hazard ratio (HR) determined by Cox regression model; confidence interval (CI)=95%.